Found 80 matching trials
Buprenorphine Naltrexone-P1 A-Cocaine PHASE1 The purpose of this study is to determine if the opioid agonist effects of ...
Show More Location
Drug Dependence Research Center
Learn More & Join Trial
IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone PHASE4 Interstitial cystitis/painful bladder syndrome (IC/PBS) is a debilitating c...
Show More Location
Center for Pelvic Health at the NorthShore University HealthSystem
Learn More & Join Trial
Sweet Preference and Alcohol Craving PHASE2 Purpose: The proposed 2-year investigation will be the first double-blind, ...
Show More Location
University of North Carolina - Chapel Hill
Learn More & Join Trial
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain PHASE3 The primary objective of the study is to determine the analgesic efficacy a...
Show More Location
Coastal Clinical Research, Inc.
Learn More & Join Trial
Understanding Treatment Response With Naltrexone Among White Alcoholics PHASE4 This is a study involving treatment for alcohol dependence among males of E...
Show More Location
University of Pennsylvania
Learn More & Join Trial
Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder PHASE4 This study will recruit 159 HIV-infected men with alcohol use disorders (AU...
Show More Location
Asociación Civil Impacta Salud y Educación
Learn More & Join Trial
Targeted Naltrexone for Problem Drinkers PHASE4 The purpose of this study is to determine whether naltrexone, combined with...
Show More Location
University of Connecticut Health Center
Learn More & Join Trial
Validation of a Test System for Development of Medications for Alcoholism PHASE3 Using theTEMA (test system for development of medications for alcoholism) i...
Show More Location
Klinik und Poliklinik für Psychiatrie und Psychotherapie
Learn More & Join Trial
Naltrexone for Antipsychotic-Induced Weight Gain NA This study is designed to look at the effects of naltrexone on weight loss ...
Show More Location
Connecticut Mental Health Center
Learn More & Join Trial
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder PHASE3 This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Show More Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)
Learn More & Join Trial